Meta Pixel

News and Announcements

London DE increased turnover by more than 50% and is seeking £1mn GBP from equity release and a further £1mn GBP from loan notes (£500K of which has already been funded)

  • Published December 16, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Key Takeaways:

  • We have added 3 new members to our management team
  • We have expanded our inventory of coloured gemstones
  • Our new sales offices have opened in the centre of Hatton Garden, London’s gemstone dealing district
  • We are ready for 2020 and new fundraising!

This year has been our best yet! Having grown our operation, raised funds and dramatically increased sales revenue, we are now seeking further funding in 2020 to take us to the next level.

Our aim is to complete our funding as a private company in 2020, grow organically and then list on the London Stock Exchange (LSE) in 2023/24. In order to achieve this we are seeking £1mn GBP from equity release and a further £1mn GBP from loan notes (£500K of which has already been funded).

This presents investors with a great choice of either a monthly coupon (10-15% PA) over a flexible term or a capital growth opportunity, with an exit strategy within 3-4 years.

We are delighted to confirm we will be attended Emergence 2020 in Sydney in February and we look forward to meeting as many people as possible on our stand.

 

About London DE

Incorporated on the 9th December 2013, London DE Limited was established as a UK based supplier of responsibly sourced gemstones, coloured gemstones and jewellery to the global market place, supplying all levels of the supply chain with loose stones and fine jewellery.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now